Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Dave Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Venture Global, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VG
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Venture Global, Inc. (NYSE: VG) pursuant and/or traceable
Bombardier Celebrates Milestone Challenger 3500 Aircraft Delivery, the 1,000th Bombardier Super-Midsize Business Jet to Take to the Skies
Bombardier Challenger 3500 aircraft Bombardier Celebrates Milestone Challenger 3500 Aircraft Delivery, the 1,000th Bombardier Super-Midsize Business Jet to Take to the Skies The milestone delivery took place with customer JM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edison International Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – EIX
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edison International (NYSE: EIX) between February 25, 2021
Saudi Arabia’s MICE Industry Poised for Significant Growth
Cynosure Worldwide expands MICE capabilities in Saudi Arabia Jowad Khan – CEO Cynosure Worldwide Jowad Khan compares the global MICE industry with Saudi Arabia’s, highlighting growth differences and opportunities. RIYADH,
PCRX DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities Class Action – PCRX
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2,